New HHS contract reviews are delaying care and filling of vacancies, IHS insiders tell Stat News. Meanwhile, KFF Health News dives into rehabilitation hospitals.

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

Kenvue has five brands that generate over $1 billion in sales—Johnson’s, Neutrogena, Listerine, Tylenol, and Aveeno—as well as a number of brands that generate over $400 million in sales: Nicorette, ...

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new ...

Kenvue said Monday that its board was taking steps to realize shareholder value and allow the company to “reach its full ...

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

Seeking Alpha's daily roundup of remarks and statements that could impact markets, sectors or individual stocks. Read more here.

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a ...